Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy
Objectives: To test the hypotheses that peak skeletonized mean diffusivity (PSMD), a measure of cerebral white matter microstructural disruption, is 1) increased in patients with cerebral amyloid angiopathy (CAA) compared to normal control (NC), mild cognitive impairment (MCI), and Alzheimer’s disea...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | NeuroImage: Clinical |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158220301170 |
_version_ | 1819278475604787200 |
---|---|
author | Cheryl R. McCreary Andrew E. Beaudin Arsenije Subotic Angela M. Zwiers Ana Alvarez Anna Charlton Bradley G. Goodyear Richard Frayne Eric E. Smith |
author_facet | Cheryl R. McCreary Andrew E. Beaudin Arsenije Subotic Angela M. Zwiers Ana Alvarez Anna Charlton Bradley G. Goodyear Richard Frayne Eric E. Smith |
author_sort | Cheryl R. McCreary |
collection | DOAJ |
description | Objectives: To test the hypotheses that peak skeletonized mean diffusivity (PSMD), a measure of cerebral white matter microstructural disruption, is 1) increased in patients with cerebral amyloid angiopathy (CAA) compared to normal control (NC), mild cognitive impairment (MCI), and Alzheimer’s disease (AD); 2) associated with neuropsychological test performance among CAA patients; and 3) increased more quickly over one year in CAA than in AD, MCI, and NC. Methods: Ninety-two participants provided a medical history, completed a neuropsychological assessment, and had a magnetic resonance (MR) exam including diffusion tensor imaging (DTI) from which PSMD was calculated. A 75-minute neuropsychological test battery was used to derive domain scores for memory, executive function, and processing speed. Multivariable analyses controlling for age and sex (and education, for cognitive outcomes) were used to test the study hypotheses. Results: PSMD was higher in the CAA group (mean 4.97 × 10−4 mm2/s) compared to NC (3.25 × 10−4 mm2/s), MCI (3.62 × 10−4 mm2/s) and AD (3.89 × 10−4 mm2/s) groups (p < .01). Among CAA patients, higher PSMD was associated with slower processing speed (estimated −0.22 standard deviation (SD) change in processing speed z score per SD increase in PSMD, 95% CI −0.42 to −0.03, p = .03), higher WMH volume [β = 0.74, CI 0.48 to 1.00], and higher CAA SVD score [β = 0.68, CI 0.24 to 1.21] but was not associated with MMSE, executive function, memory, CMB count, or cortical thickness. PSMD increased over 1-year in all groups (p < .01) but without rate differences between groups (p = .66). Conclusions: PSMD, a simple marker of diffuse global white matter heterogeneity, is increased in CAA. Our findings further support a role for white matter disruption in causing cognitive impairment in CAA. |
first_indexed | 2024-12-24T00:12:36Z |
format | Article |
id | doaj.art-702a187bbf78478db3961888e2d99802 |
institution | Directory Open Access Journal |
issn | 2213-1582 |
language | English |
last_indexed | 2024-12-24T00:12:36Z |
publishDate | 2020-01-01 |
publisher | Elsevier |
record_format | Article |
series | NeuroImage: Clinical |
spelling | doaj.art-702a187bbf78478db3961888e2d998022022-12-21T17:24:51ZengElsevierNeuroImage: Clinical2213-15822020-01-0127102280Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathyCheryl R. McCreary0Andrew E. Beaudin1Arsenije Subotic2Angela M. Zwiers3Ana Alvarez4Anna Charlton5Bradley G. Goodyear6Richard Frayne7Eric E. Smith8Corresponding author at: University of Calgary, HSC 2946, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.; Departments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Seaman Family MR Research Centre, Foothills Medical Centre, Alberta Health Sciences, Calgary, Alberta, CanadaDepartments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Seaman Family MR Research Centre, Foothills Medical Centre, Alberta Health Sciences, Calgary, Alberta, CanadaDepartments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Seaman Family MR Research Centre, Foothills Medical Centre, Alberta Health Sciences, Calgary, Alberta, CanadaDepartments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Seaman Family MR Research Centre, Foothills Medical Centre, Alberta Health Sciences, Calgary, Alberta, CanadaDepartments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Seaman Family MR Research Centre, Foothills Medical Centre, Alberta Health Sciences, Calgary, Alberta, CanadaDepartments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Seaman Family MR Research Centre, Foothills Medical Centre, Alberta Health Sciences, Calgary, Alberta, CanadaDepartments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Seaman Family MR Research Centre, Foothills Medical Centre, Alberta Health Sciences, Calgary, Alberta, CanadaDepartments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Seaman Family MR Research Centre, Foothills Medical Centre, Alberta Health Sciences, Calgary, Alberta, CanadaDepartments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Seaman Family MR Research Centre, Foothills Medical Centre, Alberta Health Sciences, Calgary, Alberta, CanadaObjectives: To test the hypotheses that peak skeletonized mean diffusivity (PSMD), a measure of cerebral white matter microstructural disruption, is 1) increased in patients with cerebral amyloid angiopathy (CAA) compared to normal control (NC), mild cognitive impairment (MCI), and Alzheimer’s disease (AD); 2) associated with neuropsychological test performance among CAA patients; and 3) increased more quickly over one year in CAA than in AD, MCI, and NC. Methods: Ninety-two participants provided a medical history, completed a neuropsychological assessment, and had a magnetic resonance (MR) exam including diffusion tensor imaging (DTI) from which PSMD was calculated. A 75-minute neuropsychological test battery was used to derive domain scores for memory, executive function, and processing speed. Multivariable analyses controlling for age and sex (and education, for cognitive outcomes) were used to test the study hypotheses. Results: PSMD was higher in the CAA group (mean 4.97 × 10−4 mm2/s) compared to NC (3.25 × 10−4 mm2/s), MCI (3.62 × 10−4 mm2/s) and AD (3.89 × 10−4 mm2/s) groups (p < .01). Among CAA patients, higher PSMD was associated with slower processing speed (estimated −0.22 standard deviation (SD) change in processing speed z score per SD increase in PSMD, 95% CI −0.42 to −0.03, p = .03), higher WMH volume [β = 0.74, CI 0.48 to 1.00], and higher CAA SVD score [β = 0.68, CI 0.24 to 1.21] but was not associated with MMSE, executive function, memory, CMB count, or cortical thickness. PSMD increased over 1-year in all groups (p < .01) but without rate differences between groups (p = .66). Conclusions: PSMD, a simple marker of diffuse global white matter heterogeneity, is increased in CAA. Our findings further support a role for white matter disruption in causing cognitive impairment in CAA.http://www.sciencedirect.com/science/article/pii/S2213158220301170Cerebral amyloid angiopathyAlzheimer’s diseaseCognitionDiffusionMagnetic resonance imaging |
spellingShingle | Cheryl R. McCreary Andrew E. Beaudin Arsenije Subotic Angela M. Zwiers Ana Alvarez Anna Charlton Bradley G. Goodyear Richard Frayne Eric E. Smith Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy NeuroImage: Clinical Cerebral amyloid angiopathy Alzheimer’s disease Cognition Diffusion Magnetic resonance imaging |
title | Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy |
title_full | Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy |
title_fullStr | Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy |
title_full_unstemmed | Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy |
title_short | Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy |
title_sort | cross sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy |
topic | Cerebral amyloid angiopathy Alzheimer’s disease Cognition Diffusion Magnetic resonance imaging |
url | http://www.sciencedirect.com/science/article/pii/S2213158220301170 |
work_keys_str_mv | AT cherylrmccreary crosssectionalandlongitudinaldifferencesinpeakskeletonizedwhitemattermeandiffusivityincerebralamyloidangiopathy AT andrewebeaudin crosssectionalandlongitudinaldifferencesinpeakskeletonizedwhitemattermeandiffusivityincerebralamyloidangiopathy AT arsenijesubotic crosssectionalandlongitudinaldifferencesinpeakskeletonizedwhitemattermeandiffusivityincerebralamyloidangiopathy AT angelamzwiers crosssectionalandlongitudinaldifferencesinpeakskeletonizedwhitemattermeandiffusivityincerebralamyloidangiopathy AT anaalvarez crosssectionalandlongitudinaldifferencesinpeakskeletonizedwhitemattermeandiffusivityincerebralamyloidangiopathy AT annacharlton crosssectionalandlongitudinaldifferencesinpeakskeletonizedwhitemattermeandiffusivityincerebralamyloidangiopathy AT bradleyggoodyear crosssectionalandlongitudinaldifferencesinpeakskeletonizedwhitemattermeandiffusivityincerebralamyloidangiopathy AT richardfrayne crosssectionalandlongitudinaldifferencesinpeakskeletonizedwhitemattermeandiffusivityincerebralamyloidangiopathy AT ericesmith crosssectionalandlongitudinaldifferencesinpeakskeletonizedwhitemattermeandiffusivityincerebralamyloidangiopathy |